Week In Review: Grail, An Oncology Diagnostics Company, Taps China Investors For $300 Million
May 26, 2018 at 17:42 PM EDT
Grail, a Hong Kong-US oncology diagnostics company, announced a $300 million C financing. The company is sequencing large populations of people -- some with cancer, some without -- to discover an early blood-based diagnostic test for cancer.
